EMA Recommends Granting a Conditional Marketing Authorisation for Autologous Anti-CD19-Transduced CD3+ Cells
Intended use is for the treatment of relapsed or refractory mantle cell lymphoma
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
Intended use is for the treatment of relapsed or refractory mantle cell lymphoma
Approval was based on KEYNOTE-204
New indication concerns the treatment of patients with unresectable advanced, recurrent or metastatic oesophageal squamous cell carcinoma
First evidence that patients with malignant mesothelioma have gender specific differences in PDGFRα expression
Evaluation of the clinical utility of two different size next-generation sequencing gene panels in solid tumours showed a preference for a larger panel across all tumour types investigated
Response was found to associate with specific biomarkers and biomarker modulations following treatment
CRISPR/Cas9 system has had a revolutionary impact on the life sciences, contributing to development of new cancer therapies
MET alterations may identify candidates for targeted therapy and signal decreased immunotherapy benefit in NSCLC
Tumour mutational burden and molecular signatures may indicate potential benefit from immunotherapy in early stage non-small cell lung cancer
Findings from an analysis of mutational spectra following radiotherapy
Advice follows the release of results from the IMpassion131 study
Evidence for efficacy is based on the results from the CheckMate-743 study
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.